Reproducibility of Dopamine Transporter Density Measured with I-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Nortropane SPECT in Phantom Studies and Parkinson’s Disease Patients
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 84476
Reproducibility of Dopamine Transporter Density Measured with I-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Nortropane SPECT in Phantom Studies and Parkinson’s Disease Patients

Authors: Yasuyuki Takahashi, Genta Hoshi, Kyoko Saito

Abstract:

Objectives: The objective of this study was to evaluate the reproducibility of I-123-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4- iodophenyl) nortropane (I-123 FP-CIT) SPECT by using specific binding ratio (SBR) in phantom studies and Parkinson’s Disease (PD) patients. Methods: We made striatum phantom originally and confirmed reproducibility. The phantom studies changed head position and accumulation of FP-CIT, each. And image processing confirms influence on SBR by 30 cases. 30 PD received a SPECT for 3 hours post injection of I-123 FP-CIT 167MBq. Results: SBR decreased in rotatory direction by the patient position by the phantom studies. And, SBR improved the influence after the attenuation and the scatter correction in the cases (y=0.99x+0.57 r2=0.83). However, Stage II recognized dispersion in SBR by low accumulation. Conclusion: Than the phantom studies that assumed the normal cases, the SPECT image after the attenuation and scatter correction had better reproducibility.

Keywords: 123I-FP-CIT, specific binding ratio, Parkinson’s disease

Procedia PDF Downloads 401